320 related articles for article (PubMed ID: 25184691)
21. In situ fluorescence monitoring of diagnosis and treatment: a versatile nanoprobe combining tumor targeting based on MUC1 and controllable DOX release by telomerase.
Si H; Wang L; Li Q; Li X; Li L; Tang B
Chem Commun (Camb); 2018 Jul; 54(59):8277-8280. PubMed ID: 29989641
[TBL] [Abstract][Full Text] [Related]
22. Multifunctional Chitosan-Capped Gold Nanoparticles for enhanced cancer chemo-radiotherapy: An invitro study.
Fathy MM; Mohamed FS; Elbialy N; Elshemey WM
Phys Med; 2018 Apr; 48():76-83. PubMed ID: 29728233
[TBL] [Abstract][Full Text] [Related]
23. Preparation and characterization of doxorubicin functionalized gold nanoparticles.
Mirza AZ; Shamshad H
Eur J Med Chem; 2011 May; 46(5):1857-60. PubMed ID: 21411194
[TBL] [Abstract][Full Text] [Related]
24. Double targeting, controlled release and reversible delivery of daunorubicin to cancer cells by polyvalent aptamers-modified gold nanoparticles.
Taghdisi SM; Danesh NM; Lavaee P; Emrani AS; Hassanabad KY; Ramezani M; Abnous K
Mater Sci Eng C Mater Biol Appl; 2016 Apr; 61():753-61. PubMed ID: 26838906
[TBL] [Abstract][Full Text] [Related]
25. AS1411 aptamer and folic acid functionalized pH-responsive ATRP fabricated pPEGMA-PCL-pPEGMA polymeric nanoparticles for targeted drug delivery in cancer therapy.
Lale SV; R G A; Aravind A; Kumar DS; Koul V
Biomacromolecules; 2014 May; 15(5):1737-52. PubMed ID: 24689987
[TBL] [Abstract][Full Text] [Related]
26. Functionalization of magnetic nanoparticles with dendritic-linear-brush-like triblock copolymers and their drug release properties.
He X; Wu X; Cai X; Lin S; Xie M; Zhu X; Yan D
Langmuir; 2012 Aug; 28(32):11929-38. PubMed ID: 22799877
[TBL] [Abstract][Full Text] [Related]
27. DNA and aptamer stabilized gold nanoparticles for targeted delivery of anticancer therapeutics.
Latorre A; Posch C; Garcimartín Y; Celli A; Sanlorenzo M; Vujic I; Ma J; Zekhtser M; Rappersberger K; Ortiz-Urda S; Somoza Á
Nanoscale; 2014 Jul; 6(13):7436-42. PubMed ID: 24882040
[TBL] [Abstract][Full Text] [Related]
28. Polyelectrolyte/Gold Nanoparticle Nanotubes Incorporating Doxorubicin-Loaded Liposomes.
Enomoto Y; Akiyama M; Morita Y; Komatsu T
Chem Asian J; 2021 Dec; 16(24):4057-4061. PubMed ID: 34664406
[TBL] [Abstract][Full Text] [Related]
29. Natural tripeptide capped pH-sensitive gold nanoparticles for efficacious doxorubicin delivery both in vitro and in vivo.
Kumar K; Moitra P; Bashir M; Kondaiah P; Bhattacharya S
Nanoscale; 2020 Jan; 12(2):1067-1074. PubMed ID: 31845927
[TBL] [Abstract][Full Text] [Related]
30. Ultrasmall gold-doxorubicin conjugates rapidly kill apoptosis-resistant cancer cells.
Zhang X; Chibli H; Mielke R; Nadeau J
Bioconjug Chem; 2011 Feb; 22(2):235-43. PubMed ID: 21189001
[TBL] [Abstract][Full Text] [Related]
31. Sustained in vitro release and cell uptake of doxorubicin adsorbed onto gold nanoparticles and covered by a polyelectrolyte complex layer.
Minati L; Antonini V; Torrengo S; Serra MD; Boustta M; Leclercq X; Migliaresi C; Vert M; Speranza G
Int J Pharm; 2012 Nov; 438(1-2):45-52. PubMed ID: 22959992
[TBL] [Abstract][Full Text] [Related]
32. Multifunctional nanoparticles for combined doxorubicin and photothermal treatments.
Park H; Yang J; Lee J; Haam S; Choi IH; Yoo KH
ACS Nano; 2009 Oct; 3(10):2919-26. PubMed ID: 19772302
[TBL] [Abstract][Full Text] [Related]
33. Aptamer-functionalized gold nanoparticles as photoresponsive nanoplatform for co-drug delivery.
Shiao YS; Chiu HH; Wu PH; Huang YF
ACS Appl Mater Interfaces; 2014 Dec; 6(24):21832-41. PubMed ID: 24949657
[TBL] [Abstract][Full Text] [Related]
34. Controlled release of a sparingly water-soluble anticancer drug through pH-responsive functionalized gold-nanoparticle-decorated liposomes.
Adhikari C; Das A; Chakraborty A
Chemphyschem; 2015 Mar; 16(4):866-71. PubMed ID: 25586408
[TBL] [Abstract][Full Text] [Related]
35. Matrix metalloproteinase triggered size-shrinkable gelatin-gold fabricated nanoparticles for tumor microenvironment sensitive penetration and diagnosis of glioma.
Ruan S; He Q; Gao H
Nanoscale; 2015 Jun; 7(21):9487-96. PubMed ID: 25909483
[TBL] [Abstract][Full Text] [Related]
36. Cyclodextrin capped gold nanoparticles as a delivery vehicle for a prodrug of cisplatin.
Shi Y; Goodisman J; Dabrowiak JC
Inorg Chem; 2013 Aug; 52(16):9418-26. PubMed ID: 23889547
[TBL] [Abstract][Full Text] [Related]
37. Integrated hollow mesoporous silica nanoparticles for target drug/siRNA co-delivery.
Ma X; Zhao Y; Ng KW; Zhao Y
Chemistry; 2013 Nov; 19(46):15593-603. PubMed ID: 24123533
[TBL] [Abstract][Full Text] [Related]
38. "Mixed-charge self-assembled monolayers" as a facile method to design pH-induced aggregation of large gold nanoparticles for near-infrared photothermal cancer therapy.
Li H; Liu X; Huang N; Ren K; Jin Q; Ji J
ACS Appl Mater Interfaces; 2014; 6(21):18930-7. PubMed ID: 25286378
[TBL] [Abstract][Full Text] [Related]
39. Development and characterization of metal oxide nanoparticles for the delivery of anticancer drug.
Sharma H; Kumar K; Choudhary C; Mishra PK; Vaidya B
Artif Cells Nanomed Biotechnol; 2016; 44(2):672-9. PubMed ID: 25406734
[TBL] [Abstract][Full Text] [Related]
40. Spherically-clustered porous Au-Ag alloy nanoparticle prepared by partial inhibition of galvanic replacement and its application for efficient multimodal therapy.
Jang H; Min DH
ACS Nano; 2015 Mar; 9(3):2696-703. PubMed ID: 25560916
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
